• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Abbott Diabetes Care Inc FreeStyle Libre 2; Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Abbott Diabetes Care Inc FreeStyle Libre 2; Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems Back to Search Results
Model Number 71992-01
Medical Device Problem Code Low Readings (2460)
Health Effect - Clinical Code Hyperglycemia (1905)
Date of Event 07/29/2026
Type of Reportable Event Serious Injury
Event or Problem Description
A low readings issue with the abbott diabetes care (adc) device was reported.The customer received an unspecified low scan on the adc device.It is unknown whether the customer noted a trend arrow on the device.The customer was asymptomatic and was unable to self-treat.The customer had contact with healthcare professional (hcp) who obtained blood glucose result of 381 mg/dl and required administration of insulin injection (dose/type unknown) for the diagnosis of hyperglycemia.There was no report of death or permanent impairment associated with this event.
 
Event or Problem Description
A low readings issue with the abbott diabetes care (adc) device was reported.The customer received an unspecified low scan on the adc device.It is unknown whether the customer noted a trend arrow on the device.The customer was asymptomatic and was unable to self-treat.The customer had contact with healthcare professional (hcp) who obtained blood glucose result of 381 mg/dl and required administration of insulin injection (dose/type unknown) for the diagnosis of hyperglycemia.There was no report of death or permanent impairment associated with this event.
 
Additional Manufacturer Narrative
Physical investigation of product is not anticipated as reporter indicated device was discarded.Investigation will be performed per adc's established processes and procedures, and a report will be submitted upon completion of investigation activities.All pertinent information available to abbott diabetes care has been submitted.
 
Additional Manufacturer Narrative
The reported product is not expected to be returned as reporter indicated the device was discarded.Therefore, no further investigation is planned.The most probable root causes associated with this failure mode are disconnected, faulty or damaged components, software/data corruption, or misuse.However, mitigations are in place to reduce and prevent such issues.All vital manufacturing steps are validated, monitored, and verified during manufacturing to ensure the system is in conformance with the verified design.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.This also serves as a correction report.D4 - expiration date was incorrectly documented in the previous report.Correction has been made.At this time, the product has not yet been returned for this complaint.An extended investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.Dhrs (device history review) for the libre sensor and sensor kit was reviewed and the dhrs showed the libre sensor and sensor kit met specifications prior to release to distribution.In the event that product is received, a physical investigation will be performed per adc's established processes and procedures and a report will be submitted upon completion of investigation.All pertinent information available to abbott diabetes care has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FreeStyle Libre 2
Common Device Name
Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems
Manufacturer (Section D)
Abbott Diabetes Care Inc
1360 south loop road
alameda CA 94502 -700
Manufacturer Contact
melissa pieplow
1360 south loop road
alameda, CA 94502--700
+1(510)384-5975
MDR Report Key50483199
Report Number2954323-2026-297084
Device Sequence Number10234210
Product Code QLG
UDI-Device Identifier00357599836016
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K193371
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 09/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date07/31/2026
Device Model Number71992-01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/30/2026
Supplement Date Received by Manufacturer09/07/2026
Initial Report FDA Received Date08/27/2026
Supplement Report FDA Received Date09/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/07/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age73 YR
Patient SexFemale
-
-